{"entity":{"type":"insider","cik":"0001522478","url":"/insider/0001522478","json_url":"/insider/0001522478.json","name":"FREEMAN KEVIN D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":36,"first":"2013-05-30","last":"2025-12-23","span_basis":"filed_date"},"name_variants":[{"name":"FREEMAN KEVIN D","source":"filing","n_filings":36,"first_seen":"2013-05-30","last_seen":"2025-12-23"}],"transactions":[{"id":9228237,"accession":"0001133416-25-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-25-000081","line_url":"/filing/0001133416-25-000081#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":3.548,"price_display":"3.55","price_state":"stated","total_value":19514.0,"total_display":"19,514.00","total_whole":"19,514","shares_owned_after":55269.0,"shares_owned_after_display":"55,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-23","scope":"insider"},{"id":9228236,"accession":"0001133416-25-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-25-000080","line_url":"/filing/0001133416-25-000080#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":3.548,"price_display":"3.55","price_state":"stated","total_value":19514.0,"total_display":"19,514.00","total_whole":"19,514","shares_owned_after":55269.0,"shares_owned_after_display":"55,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-23","scope":"insider"},{"id":4794842,"accession":"0001133416-25-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-25-000075","line_url":"/filing/0001133416-25-000075#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":3.548,"price_display":"3.55","price_state":"stated","total_value":19514.0,"total_display":"19,514.00","total_whole":"19,514","shares_owned_after":55269.0,"shares_owned_after_display":"55,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-23","scope":"insider"},{"id":5024101,"accession":"0001133416-25-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-25-000033","line_url":"/filing/0001133416-25-000033#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.899,"price_display":"2.90","price_state":"stated","total_value":14495.0,"total_display":"14,495.00","total_whole":"14,495","shares_owned_after":49769.0,"shares_owned_after_display":"49,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-07-18","scope":"insider"},{"id":2174031,"accession":"0001133416-24-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-24-000062","line_url":"/filing/0001133416-24-000062#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.8134,"price_display":"0.81","price_state":"stated","total_value":8134.0,"total_display":"8,134.00","total_whole":"8,134","shares_owned_after":44769.0,"shares_owned_after_display":"44,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-24","filed_date":"2024-12-26","scope":"insider"},{"id":2584074,"accession":"0001133416-24-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-24-000058","line_url":"/filing/0001133416-24-000058#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1300.0,"shares_display":"1,300","price_per_share":2.64,"price_display":"2.64","price_state":"stated","total_value":3432.0,"total_display":"3,432.00","total_whole":"3,432","shares_owned_after":34769.0,"shares_owned_after_display":"34,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-17","filed_date":"2024-10-17","scope":"insider"},{"id":2349204,"accession":"0001133416-24-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001133416-24-000056","line_url":"/filing/0001133416-24-000056","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":27000.0,"total_display":"27,000.00","total_whole":"27,000","shares_owned_after":80000.0,"shares_owned_after_display":"80,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-16","scope":"insider","n_lines":2},{"id":2886279,"accession":"0001133416-24-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-24-000044","line_url":"/filing/0001133416-24-000044#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.3799,"price_display":"2.38","price_state":"stated","total_value":5949.75,"total_display":"5,949.75","total_whole":"5,950","shares_owned_after":28469.0,"shares_owned_after_display":"28,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-20","filed_date":"2024-06-20","scope":"insider"},{"id":3204286,"accession":"0001133416-24-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-24-000038","line_url":"/filing/0001133416-24-000038#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.98,"price_display":"2.98","price_state":"stated","total_value":7450.0,"total_display":"7,450.00","total_whole":"7,450","shares_owned_after":25969.0,"shares_owned_after_display":"25,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-22","filed_date":"2024-04-22","scope":"insider"},{"id":6974945,"accession":"0001133416-22-000093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-22-000093","line_url":"/filing/0001133416-22-000093#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.41,"price_display":"1.41","price_state":"stated","total_value":14100.0,"total_display":"14,100.00","total_whole":"14,100","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-10-31","scope":"insider"},{"id":6522567,"accession":"0001133416-22-000063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-22-000063","line_url":"/filing/0001133416-22-000063#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.3299,"price_display":"1.33","price_state":"stated","total_value":6649.5,"total_display":"6,649.50","total_whole":"6,650","shares_owned_after":65000.0,"shares_owned_after_display":"65,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-20","scope":"insider"},{"id":6748129,"accession":"0001133416-22-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-22-000057","line_url":"/filing/0001133416-22-000057#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":8550.0,"total_display":"8,550.00","total_whole":"8,550","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-18","filed_date":"2022-04-18","scope":"insider"},{"id":9228234,"accession":"0001133416-22-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-22-000010","line_url":"/filing/0001133416-22-000010#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.9612,"price_display":"1.96","price_state":"stated","total_value":9806.0,"total_display":"9,806.00","total_whole":"9,806","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-19","filed_date":"2022-01-19","scope":"insider"},{"id":6128449,"accession":"0001133416-22-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-22-000008","line_url":"/filing/0001133416-22-000008#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.9612,"price_display":"1.96","price_state":"stated","total_value":9806.0,"total_display":"9,806.00","total_whole":"9,806","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-19","filed_date":"2022-01-19","scope":"insider"},{"id":9228233,"accession":"0001133416-21-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-21-000027","line_url":"/filing/0001133416-21-000027#line-1","is_derivative":false,"issuer_cik":"0001522478","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001522478","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":11400.0,"total_display":"11,400.00","total_whole":"11,400","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-15","scope":"insider"},{"id":4627316,"accession":"0001133416-21-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-21-000025","line_url":"/filing/0001133416-21-000025#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":11400.0,"total_display":"11,400.00","total_whole":"11,400","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-15","scope":"insider"},{"id":4294265,"accession":"0001133416-21-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-21-000023","line_url":"/filing/0001133416-21-000023#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":11700.0,"total_display":"11,700.00","total_whole":"11,700","shares_owned_after":45000.0,"shares_owned_after_display":"45,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-06","scope":"insider"},{"id":5110741,"accession":"0001133416-21-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-21-000017","line_url":"/filing/0001133416-21-000017#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":6340.0,"total_display":"6,340.00","total_whole":"6,340","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-29","filed_date":"2021-11-01","scope":"insider"},{"id":4593985,"accession":"0001133416-21-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-21-000013","line_url":"/filing/0001133416-21-000013#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.19,"price_display":"3.19","price_state":"stated","total_value":6380.0,"total_display":"6,380.00","total_whole":"6,380","shares_owned_after":38000.0,"shares_owned_after_display":"38,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-21","filed_date":"2021-10-21","scope":"insider"},{"id":5511302,"accession":"0001133416-21-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-21-000011","line_url":"/filing/0001133416-21-000011#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.3689,"price_display":"3.37","price_state":"stated","total_value":10106.7,"total_display":"10,106.70","total_whole":"10,107","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-19","filed_date":"2021-10-19","scope":"insider"},{"id":4780276,"accession":"0001140361-21-032248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-21-032248","line_url":"/filing/0001140361-21-032248#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.877,"price_display":"3.88","price_state":"stated","total_value":11631.0,"total_display":"11,631.00","total_whole":"11,631","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-23","filed_date":"2021-09-23","scope":"insider"},{"id":5187686,"accession":"0000899243-21-015010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-015010","line_url":"/filing/0000899243-21-015010#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":10200.0,"total_display":"10,200.00","total_whole":"10,200","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-06","scope":"insider"},{"id":3075466,"accession":"0000899243-20-024607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-024607","line_url":"/filing/0000899243-20-024607#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.5696,"price_display":"2.57","price_state":"stated","total_value":12848.0,"total_display":"12,848.00","total_whole":"12,848","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-04","filed_date":"2020-09-09","scope":"insider"},{"id":2541435,"accession":"0000899243-20-009061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-009061","line_url":"/filing/0000899243-20-009061#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":1.6407,"price_display":"1.64","price_state":"stated","total_value":9844.2,"total_display":"9,844.20","total_whole":"9,844","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-19","filed_date":"2020-03-20","scope":"insider"},{"id":8308715,"accession":"0000899243-19-027471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-027471","line_url":"/filing/0000899243-19-027471#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.3586,"price_display":"3.36","price_state":"stated","total_value":10075.8,"total_display":"10,075.80","total_whole":"10,076","shares_owned_after":14000.0,"shares_owned_after_display":"14,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-18","scope":"insider"},{"id":8761794,"accession":"0000899243-19-023102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-023102","line_url":"/filing/0000899243-19-023102#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1290.0,"shares_display":"1,290","price_per_share":3.71,"price_display":"3.71","price_state":"stated","total_value":4785.9,"total_display":"4,785.90","total_whole":"4,786","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-06","filed_date":"2019-09-09","scope":"insider"},{"id":7864792,"accession":"0001179022-19-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-19-000035","line_url":"/filing/0001179022-19-000035","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9136.0,"shares_display":"9,136","price_per_share":4.28,"price_display":"4.28","price_state":"stated","total_value":39102.08,"total_display":"39,102.08","total_whole":"39,102","shares_owned_after":9710.0,"shares_owned_after_display":"9,710","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-03","scope":"insider","n_lines":2},{"id":7906036,"accession":"0001179022-19-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-19-000028","line_url":"/filing/0001179022-19-000028#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.73,"price_display":"4.73","price_state":"stated","total_value":2365.0,"total_display":"2,365.00","total_whole":"2,365","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-05","filed_date":"2019-04-08","scope":"insider"},{"id":7786283,"accession":"0001179022-19-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-19-000025","line_url":"/filing/0001179022-19-000025#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":4.285,"price_display":"4.28","price_state":"stated","total_value":6427.5,"total_display":"6,427.50","total_whole":"6,428","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-08","filed_date":"2019-02-11","scope":"insider"},{"id":6462939,"accession":"0001179022-18-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-18-000013","line_url":"/filing/0001179022-18-000013#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.0955,"price_display":"4.10","price_state":"stated","total_value":8191.0,"total_display":"8,191.00","total_whole":"8,191","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-02","scope":"insider"},{"id":6009364,"accession":"0001179022-18-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-18-000012","line_url":"/filing/0001179022-18-000012#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.0955,"price_display":"4.10","price_state":"stated","total_value":8191.0,"total_display":"8,191.00","total_whole":"8,191","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-02","scope":"insider"},{"id":4333151,"accession":"0001179022-17-000070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-17-000070","line_url":"/filing/0001179022-17-000070","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8400.0,"shares_display":"8,400","price_per_share":1.626442857142857,"price_display":"1.63","price_state":"stated","total_value":13662.12,"total_display":"13,662.12","total_whole":"13,662","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-07","filed_date":"2017-12-08","scope":"insider","n_lines":2},{"id":8569108,"accession":"0001179022-15-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-15-000078","line_url":"/filing/0001179022-15-000078#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2083.0,"shares_display":"2,083","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":5624.1,"total_display":"5,624.10","total_whole":"5,624","shares_owned_after":2083.0,"shares_owned_after_display":"2,083","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-02","scope":"insider"},{"id":6598019,"accession":"0000914062-14-000228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-14-000228","line_url":"/filing/0000914062-14-000228#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":4700.0,"total_display":"4,700.00","total_whole":"4,700","shares_owned_after":3917.0,"shares_owned_after_display":"3,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-15","filed_date":"2014-08-18","scope":"insider"},{"id":5350247,"accession":"0000914062-13-000326","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000326","line_url":"/filing/0000914062-13-000326#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.0776,"price_display":"6.08","price_state":"stated","total_value":6077.6,"total_display":"6,077.60","total_whole":"6,078","shares_owned_after":2917.0,"shares_owned_after_display":"2,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-19","scope":"insider"},{"id":5096280,"accession":"0000914062-13-000188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000188","line_url":"/filing/0000914062-13-000188#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001522478","owner_name":"FREEMAN KEVIN D","owner_display_name":"FREEMAN KEVIN D","owner_url":"/insider/0001522478","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.2115,"price_display":"4.21","price_state":"stated","total_value":4211.5,"total_display":"4,211.50","total_whole":"4,212","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-28","filed_date":"2013-05-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":39,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001133416","name":"GALECTIN THERAPEUTICS INC","url":"/issuer/0001133416","role":"Director","n_filings":36,"first_seen":"2013-05-30","last_seen":"2025-12-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001522478","retrieved_at":"2026-08-26T07:11:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}